Irving

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Depression2 trials

Phase

• Phase 22 trials

Status

• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Seaport Therapeutics2 trials

Running trials

• Enrolling by invitation

  An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)

  NCT07161700· Phase 2· Seaport Therapeutics· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

  NCT07065240· Phase 2· Seaport Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression2 recruiting